Four years ago, many shareholders were impressed primarily with the science; that hasn't changed. However, the fundamental understanding regarding mechanism, potential combination treatments, and automation have all improved significantly and should galvanize excitement.
Four years ago, we weren't even close in terms of regulatory submissions and automated manufacturing. Today, our application has been in the hands of the MHRA for over a year, and the Edens system is nearing completion.
Four years ago, the 7 defendants could spoof at will. Today they are on the "precipice" of discovery.
Don't let the share price manipulation and paid FUDsters affect your mindset this late in the game.
Market Data 
Markets 
AI
